ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

A Study of Brain Radiotherapy With Lapatinib in HER2+ Breast Cancer

Julia White, MD
Published Online:1:17 PM, Thu December 22, 2016

Julia White, MD, professor of Radiation Oncology, Ohio State University, discusses a phase II study of whole brain radiotherapy with concurrent lapatinib in patients with brain metasteses from HER2-positive breast cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.